CVS is a healthcare company that operates retail pharmacies and has its headquarters in the United States. To give it its full name, the company is called CVS Health Corporation. It is responsible for operating a nationwide chain that includes clinics, retail locations, and pharmacies. With more than 9,900 retail locations and 295,000 employees, CVS is one of the largest pharmaceutical chains in the United States. The article will explain the Top CVS Shareholders and best CVS shareholders (CVS).

What are CVS Shareholders (CVS)?

CVS Shareholders (CVS) refers to the individuals and organizations that own shares in CVS Health Corporation. Shareholders can access a portion of the company's profits and ownership in a business section. Moreover, voting rights on specific firm decisions, such as the election of the board of directors, are a perk of ownership.

CVS has a large number of shareholders, which includes institutional investors in addition to individual individuals that own shares of the company directly. Institutional investors often make up most of CVS's top shareholders because they own significant amounts of the company's stock.

The Top CVS Shareholders

The four Top CVS Shareholders are listed below.

Larry J. Merlo

CVS Health Corp. is led by Larry J. Merlo, the company's director, president, and chief executive officer. After CVS purchased People's Drug in 1990, he began working as an on-site assistant manager for the corporation. He had worked his way up through the ranks to become the Chief Executive Officer of the world's most successful pharmacy and drugstore business. Thanks to his leadership, CVS has made significant progress in rapidly expanding its health department. Merlo is the single-largest individual shareholder in the corporation, with a combined total of 700,000 shares in the company's stock.

Helena Foulkes

Helena Foulkes previously served as the head of the pharmacy business of CVS. Since 2014, when he was first appointed to the role, he has served in that capacity until she retired from the organization in February of 2018. Since he started working with CVS in 1992, he has also held various other positions there.

He was promoted to the chief executive officer of Hudon's Bay Company in February 2018. As of the 16th of February in 2018, Foulkes owns 45,107 shares of CVS, even though her ownership of the business's stock may be susceptible to change once she leaves the company.

C. David Brown II

C. David Brown II is the individual stakeholder who holds the second-largest stake in CVS and also serves on the board of directors for the corporation. He formerly held a position on the board of directors for Caremark Rx, Inc.

Also, he is a director for Rayonier Advanced Materials, and in the past, he was the head of the board for the law firm Broad and Cassel, located in Florida. In a report filed with the SEC on May 4, 2018, he said that he owned 101,252 shares of CVS.

Troyen A. Brennan

Troyen A. Brennan serves as the company's Executive Vice President. He has been named as executive vice president and chief medical officer in anticipation of the $69 billion Aetna Inc. acquisition, which is expected to finalize later this year.

According to an SEC filing from April 1, 2018, Brennan owns 84,723 shares of CVS stock. This tends to make him the third largest shareholder in the company.

Best CVS Shareholders (CVS)

All four of these investors are considered major institutional players, making them CVS's most valuable stockholders. Together, they hold a sizable share of the business and substantially impact the decisions made there, as well as the overall course it takes. The following companies make up the Best CVS Shareholders (CVS)

The Vanguard Group, Inc.

The Vanguard Group is the company that owns the most CVS stock on an institutional level. As of 2021, it has more than 82 million outstanding shares. This accounts for around 7.4 percent of CVS's total outstanding shares.

A key player in the investment management industry, the Vanguard Group was founded in 1974. Individual and institutional investors can choose from various financial instruments, including exchange-traded funds, mutual funds, and other products offered by the company.

BlackRock, Inc.

CVS also counts BlackRock as one of its significant institutional shareholders. As of the year 2021, it has more than 76 million outstanding shares. This amounts to around 6.9% of CVS's total shares in circulation. BlackRock is a multinational investment management company that currently oversees assets worth over $9 trillion on behalf of clients worldwide.

State Street Corporation

The State Street Company currently controls more than 50 million CVS shares. This accounts for around 4.6% of the total shares in circulation for the corporation. The State Street Corporation provides investment management, research, and trading services to institutional investors. It is a corporation that operates in the financial services industry.

Wellington Management Company, LLP

The CVS stock held by Wellington Management Corporation is more than 35 million shares. This amounts to around 3.2% of the total shares in circulation for the corporation. The Wellington Management Company is an investment management company that works with clients worldwide to provide them with financial solutions and services.

To Wrap Up

CVS provides customers with a variety of medical supplies and services. It covers prescription and over-the-counter medicines, products for health and beauty, and medical supplies. Also, the organization is in charge of running the MinuteClinic.

It is a walk-in medical clinic network housed within some of the company's retail locations. Patients can obtain treatment for relatively minor injuries and illnesses at these clinics. In addition to that, CVS offers services related to the management of pharmacy benefits. Managing the prescription drug benefits for various health plans and employers are entailed in this process.